Vic E. Myer

Active 1997–2025

30
Papers
20,367
Citations
27
h-index
30
i10-index

Citations

Citations per year for Vic E. Myer1948: 1 citations1961: 1 citations1990: 1 citations1996: 1 citations1997: 3 citations1998: 19 citations1999: 39 citations2000: 44 citations2001: 38 citations2002: 35 citations2003: 23 citations2004: 22 citations2005: 16 citations2006: 12 citations2007: 13 citations2008: 13 citations2009: 29 citations2010: 80 citations2011: 142 citations2012: 264 citations2013: 367 citations2014: 363 citations2015: 427 citations2016: 417 citations2017: 427 citations2018: 455 citations2019: 1,067 citations2020: 1,053 citations2021: 1,030 citations2022: 780 citations2023: 564 citations2024: 839 citations2025: 440 citations2026: 36 citations1949–1960: no citations, so these years are not shown1962–1989: no citations, so these years are not shown1991–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,441 citing papers, 32.7% of this breakdownChina: 1,770 citing papers, 13% of this breakdownUnited Kingdom: 841 citing papers, 6.2% of this breakdownGermany: 777 citing papers, 5.7% of this breakdownCanada: 453 citing papers, 3.3% of this breakdownJapan: 405 citing papers, 3% of this breakdownFrance: 401 citing papers, 3% of this breakdownSwitzerland: 400 citing papers, 2.9% of this breakdownItaly: 394 citing papers, 2.9% of this breakdownNetherlands: 299 citing papers, 2.2% of this breakdownAustralia: 292 citing papers, 2.2% of this breakdownSpain: 268 citing papers, 2% of this breakdown
0%32.7%Other 20.9%

Fields

  • Biochemistry, Genetics and Molecular Biology60.8%
  • Medicine26.4%
  • Computer Science6.5%
  • Immunology and Microbiology2.1%
  • Neuroscience1.3%
  • Chemistry0.6%
  • Other2.3%

Topics

  • CRISPR and Genetic Engineering3.7%
  • Computational Drug Discovery Methods3.5%
  • Bioinformatics and Genomic Networks2.7%
  • RNA modifications and cancer2.6%
  • Epigenetics and DNA Methylation2.4%
  • Cancer Genomics and Diagnostics2.4%
  • Other82.7%

Coauthors

All papers

Open in search
  1. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 8,599

  2. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fred Harbinski, John A. Tallarico, Christopher J. Wilson, Vic E. Myer, Jeffery A. Porter, Dirksen E. Bussiere, Peter M. Finan, Mark Labow, Xiaohong Mao, Lawrence G. Hamann, Brendan D. Manning, Reginald Valdez, Thomas Nicholson, Markus Schirle, Mark Knapp, Erin P. Keaney, Leon O. Murphy - Nature Cell Biology 2014 cited by 740

  3. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maxwell N. Skor, Pam Stetkiewicz, Tongyao Wang, Clifford Yudkoff, Vic E. Myer, Charles F. Albright, Haiyan Jiang - Nature Medicine 2019 cited by 706

  4. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter M. Finan, John A. Tallarico, Tewis Bouwmeester, Jeffery A. Porter, Andreas Bauer, Feng Cong - Nature 2009 cited by 2,099

  5. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

    Authors: , , , , , , , , , , , , , , , , - Cell 2009 cited by 1,787

  6. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Billig, Saskia M. Brachmann, Frank P. Buxton, Roger Caothien, Justina X. Caushi, Franklin Chung, Marta Cortés-Cros, Rosalie deBeaumont, Clara Delaunay, Aurore Desplat, William Duong, Donald A. Dwoske, Richard S. Eldridge, Ali Farsidjani, Fei Feng, Jiajia Feng, Daisy Flemming, William C. Forrester, Giorgio Giacomo Galli, Zhenhai Gao, François Gauter, Veronica Gibaja, Kristy Haas, Marc Hattenberger, Tami Hood, Kristen E. Hurov, Zainab Jagani, Mathias Jenal, Jennifer Johnson, Michael D. Jones, Avnish Kapoor, Joshua M. Korn, Jilin Liu, Qiumei Liu, Shumei Liu, Yue Liu, Alice Loo, Kaitlin J. Macchi, Typhaine Martin, Gregory McAllister, Amandine Meyer, Sandra Mollé, Raymond Pagliarini, Tanushree Phadke, Brian Repko, Tanja Schouwey, Frances Shanahan, Qiong Shen, Christelle Stamm, Christine Stephan, Volker M. Stucke, Ralph Tiedt, Malini Varadarajan, K. Venkatesan, Alberto C. Vitari, Marco Wallroth, Jan Weiler, Jing Zhang, Craig Mickanin, Vic E. Myer, Jeffery A. Porter, Albert Lai, Hans Bitter, Emma Lees, Nicholas Keen, Audrey Kauffmann, Frank Stegmeier, Francesco Hofmann, Tobias Schmelzle, William R. Sellers - Cell 2017 cited by 712

  7. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 416

  8. AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 172

  9. SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian S. Tseng, Jeffery A. Porter, Vic E. Myer, John A. Tallarico, Lawrence G. Hamann, Daniel Curtis, Mark C. Fishman, William F. Dietrich, Natalie A. Dales, Rajeev Sivasankaran - Nature Chemical Biology 2015 cited by 428

  10. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling

    Authors: , , , , , , , , , , , , , , - Nature Cell Biology 2011 cited by 434

  11. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William R. Sellers, Robert Schlegel, Jennifer A. Wargo, William C. Hahn, Levi A. Garraway - Nature 2010 cited by 1,465

  12. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity

    Authors: , , - Molecular Cell 2016 cited by 310

  13. PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Chemistry & Biology 2013 cited by 225

  14. UDiTaS™, a genome editing detection method for indels and genome rearrangements

    Authors: , , , , , , , , , , , , , - BMC Genomics 2018 cited by 139

  15. Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus

    Authors: , , , , , , , , , , , - Nature Communications 2017 cited by 198

  16. Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T Cells

    Authors: , , , , , , , , , , - The CRISPR Journal 2020 cited by 59

  17. A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2025 cited by 82

  18. EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD

    Authors: , , , , , , , , , , , , , , , - Blood 2019 cited by 32

  19. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 112

  20. Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2012 cited by 107

  21. R-Spondin Potentiates Wnt/β-Catenin Signaling through Orphan Receptors LGR4 and LGR5

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 172

  22. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity

    Authors: , , , , , , , , , , - PLoS ONE 2020 cited by 18

  23. Identification of HuR as a protein implicated in AUUUA‐mediated mRNA decay

    Authors: , , - The EMBO Journal 1997 cited by 303

  24. Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Virology 2009 cited by 197